Viewing Study NCT04721795


Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2025-12-27 @ 10:10 PM
Study NCT ID: NCT04721795
Status: COMPLETED
Last Update Posted: 2023-12-08
First Post: 2021-01-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)
Sponsor: Obafemi Awolowo University Teaching Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: ERC/2020/10/05
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View